// App-Quantinova.ai

: OBESITY REMAINS A MAJOR RISK FACTOR ASSOCIATED WITH VASCULAR STIFFENING IN TYPE 2 DIABETES

Researchers

Presenter

  • Currie, G

Principal Investigators

  • Flynn, J

  • Rossing, P

  • Delles, C

Medical Centers

  • Institute of Cardiovascular Sciences, University of Glasgow, Glasgow, UNITED KINGDOM

  • Steno Diabetes Center, Gentofte, Copenhagen, DENMARK

  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Locations

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

  • Nephrology

Disease

  • Diabetic nephropathy

  • Microalbuminuria

  • Type 2 diabetes mellitus

  • Renal disease

  • Diabetes

  • Obesity

Biomarkers

  • Renin

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved